Aspira Women's Health Inc.
AWHL· OTC
Released Aug 10, 2022, after the close
10-Q filed Aug 10, 2022, 41 days after period end · 0000926617-22-000052
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $2.07M | $1.80M | $746.00K | $1.14M |
| Net Income | -$8.24M | -$7.07M | -$3.83M | -$4.31M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$1.10 |
| -$0.06 |
| -$0.04 |
| -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.